Aimei Health Files 8-K on Shareholder Votes & Financials
Ticker: AFJKR · Form: 8-K · Filed: Dec 31, 2024 · CIK: 1979005
Sentiment: neutral
Topics: corporate-governance, financial-reporting
TL;DR
Aimei Health filed an 8-K for shareholder votes and financials. Check for updates.
AI Summary
Aimei Health Technology Co., Ltd. filed an 8-K on December 23, 2024, reporting on matters submitted to a vote of security holders and financial statements. The company is incorporated in the Cayman Islands and has its principal executive offices in New York, NY.
Why It Matters
This filing provides updates on corporate governance and financial reporting for Aimei Health Technology Co., Ltd., which is important for investors to understand the company's operational status.
Risk Assessment
Risk Level: low — This is a routine filing reporting on shareholder votes and financial statements, not indicating any immediate operational or financial distress.
Key Players & Entities
- Aimei Health Technology Co., Ltd. (company) — Registrant
- December 23, 2024 (date) — Date of earliest event reported
- 10 East 53rd Street, Suite 3001, New York, NY 10022 (address) — Business and Mail Address
- Cayman Islands (jurisdiction) — State or other jurisdiction of incorporation
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates that 'Submission of Matters to a Vote of Security Holders' is an item reported, but the specific details of these matters are not provided in the excerpt.
What financial statements are being reported?
The filing lists 'Financial Statements and Exhibits' as an item, but the specific financial statements are not detailed in this excerpt.
When was the earliest event reported in this 8-K?
The earliest event reported was on December 23, 2024.
Where is Aimei Health Technology Co., Ltd. incorporated?
Aimei Health Technology Co., Ltd. is incorporated in the Cayman Islands.
What is the company's primary business address?
The company's business address is 10 East 53rd Street, Suite 3001, New York, NY 10022.
Filing Stats: 924 words · 4 min read · ~3 pages · Grade level 13.5 · Accepted 2024-12-31 16:10:17
Key Financial Figures
- $0.0001 — registered Ordinary Shares, par value $0.0001 per share AFJK The Nasdaq Stock Mar
- $0.033 — its initial business combination, from $0.033 per Public Share (for each monthly exte
- $50,000 — to an amount equal to the lesser of (i) $50,000 for all outstanding Public Shares and (
Filing Documents
- form8-k.htm (8-K) — 56KB
- 0001493152-24-052702.txt ( ) — 282KB
- afjk-20241223.xsd (EX-101.SCH) — 4KB
- afjk-20241223_def.xml (EX-101.DEF) — 30KB
- afjk-20241223_lab.xml (EX-101.LAB) — 37KB
- afjk-20241223_pre.xml (EX-101.PRE) — 27KB
- form8-k_htm.xml (XML) — 7KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 31, 2024 Aimei Health Technology Co., Ltd By: /s/ Junheng Xie Name: Junheng Xie Title: Chief Executive Officer